Published in Drug Law Weekly, September 9th, 2008
As the fastest growing segment of the Chinese healthcare industry, China's biopharma industry is ranked third among its pharmaceutical segment. Biopharma product output and sales revenue generating 8% of total pharma sales, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.